Emmanuelle Sarzi

Emmanuelle Sarzi

Auto-generated profile, based on publicly available information

Emmanuelle Sarzi

Institute of Neurosciences of Montpellier, INSERM, University of Montpellier, Montpellier, France

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2007 in Nature Genetics
Verified
Journal Article
Closed access
ABAlice Bourdon
Alice Bourdon
LMLimor Minai
Limor Minai
VSValérie Serre
Valérie Serre
JJJean-Philippe Jais
Jean-Philippe Jais
ESEmmanuelle Sarzi
Emmanuelle Sarzi
ARAgnès Rötig
Agnès Rötig

2 April 2006 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
ASAntonella Spinazzola
Antonella Spinazzola
CVCarlo Viscomi
Carlo Viscomi
EFErika Fernández-Vizarra
Erika Fernández-Vizarra
FCFranco Carrara
Franco Carrara
ADAdamo Pio d'Adamo
Adamo Pio d'Adamo
Massimo ZevianiMassimo Zeviani
Massimo Zeviani

25 October 2010 in Genome Research
Verified
Journal Article
Open access
PDF file
GEGhizlane Elachouri
Ghizlane Elachouri
SVSara Vidoni
Sara Vidoni
CZClaudia Zanna
Claudia Zanna
APAlexandre Pattyn
Alexandre Pattyn
HBHASSAN BOUKHADDAOUI
HASSAN BOUKHADDAOUI
GLGuy Lenaers
Guy Lenaers
Eukaryotic cells harbor a small multiploid mitochondrial genome, organized in nucleoids spread within the mitochondrial network. Maintenance and distribution of mitochondrial DNA (mtDNA) are essential for energy metabolism, mitochondrial lineage in primordial germ cells, and to prevent mtDNA instability, which leads to many debilitating human diseases. Mounting evidence suggests that the actors of the mitochondrial network dynamics, among which is the intramitochondrial dynamin OPA1, might be involved in these processes. Here, using siRNAs specific to OPA1 alternate spliced exons, we evidenced that silencing of the OPA1 variants including exon 4b leads to mtDNA depletion, secondary to inhibition of mtDNA replication, and to marked alteration of mtDNA distribution in nucleoid and nucleoid distribution throughout the mitochondrial network. We demonstrate that a small hydrophobic 10-kDa peptide generated by cleavage of the OPA1-exon4b isoform is responsible for this process and show that this peptide is embedded in the inner membrane and colocalizes and coimmunoprecipitates with nucleoid components. We propose a novel synthetic model in which a peptide, including two trans-membrane domains derived from the N terminus of the OPA1-exon4b isoform in vertebrates or from its ortholog in lower eukaryotes, might contribute to nucleoid attachment to the inner mitochondrial membrane and promotes mtDNA replication and distribution. Thus, this study places OPA1 as a direct actor in the maintenance of mitochondrial genome integrity.

24 August 2007 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
ESEmmanuelle Sarzi
Emmanuelle Sarzi
SGSteffi Goffart
Steffi Goffart
VSValérie Serre
Valérie Serre
DCDominique Chrétien
Dominique Chrétien
ASAbdelhamid Slama
Abdelhamid Slama
ARAgnès Rötig
Agnès Rötig

1 May 2007 in The Journal of Pediatrics
Verified
Journal Article
Closed access
ESEmmanuelle Sarzi
Emmanuelle Sarzi
ABAlice Bourdon
Alice Bourdon
DCDominique Chrétien
Dominique Chrétien
MZMohamed Zarhrate
Mohamed Zarhrate
JCJohanna Corcos
Johanna Corcos
ARAgnès Rötig
Agnès Rötig

14 December 2012 in Brain
Verified
Journal Article
Open access
PDF file
ESEmmanuelle Sarzi
Emmanuelle Sarzi
CAClaire Angebault
Claire Angebault
MSMarie Seveno
Marie Seveno
NGNaïg Gueguen
Naïg Gueguen
BCBenjamin Chaix
Benjamin Chaix
GLGuy Lenaers
Guy Lenaers
Dominant optic atrophy is a rare inherited optic nerve degeneration caused by mutations in the mitochondrial fusion gene OPA1. Recently, the clinical spectrum of dominant optic atrophy has been extended to frequent syndromic forms, exhibiting various degrees of neurological and muscle impairments frequently found in mitochondrial diseases. Although characterized by a specific loss of retinal ganglion cells, the pathophysiology of dominant optic atrophy is still poorly understood. We generated an Opa1 mouse model carrying the recurrent Opa1delTTAG mutation, which is found in 30% of all patients with dominant optic atrophy. We show that this mouse displays a multi-systemic poly-degenerative phenotype, with a presentation associating signs of visual failure, deafness, encephalomyopathy, peripheral neuropathy, ataxia and cardiomyopathy. Moreover, we found premature age-related axonal and myelin degenerations, increased autophagy and mitophagy and mitochondrial supercomplex instability preceding degeneration and cell death. Thus, these results support the concept that Opa1 protects against neuronal degeneration and opens new perspectives for the exploration and the treatment of mitochondrial diseases.